andrew huberman on glp 1 “Everyone Should be a GLP-1 Medication”, “Should everyone just be on a GLP-1?” Wrong question. The real question is: How do we USE GLP-1s effectively? Because this isn’t GLP-1 vs. lifestyle change… GLP-1s: Overdosing, Side Effects &

Ipamorelin, a selective ghrelin/GHS-R agonist and GH secretagogue

The barrier becomes confused: one day its nourished, the next day its inflamed, and the cycle continues

What Happens: GLP-1 medications cross the blood-brain barrier Activate receptors in appetite control regions Reduce hunger signals Increase satiety (feeling of fullness) Decrease reward response to food Reduce obsessive thoughts about food What You Experience: Less frequent hunger Feel satisfied with smaller portions Dont think about food constantly Reduced cravings for specific foods Easier to say no to unnecessary eating This is the primary mechanismyou naturally eat less because you genuinely want less food

The reciprocal substitution had no significant effect on Venus-mG s recruitment to GIPR, and neither substitution affected the ability of GLP-1 or GIP to recruit Venus-mG q to either the wild-type or the chimeric receptor (Figures 2C,E,H